ABSTRACT
INTRODUCTION
On the basis of serological and genetical data, coronaviruses are classified into three different serogroups (Siddell, 1995) . The members of serogroup I utilise the cell surface molecule aminopeptidase N (APN) as a receptor (Delmas et aI., 1992; Yeager et aI., 1992; Tresnan et aI., 1996) . Human APN and porcine APN act species specifically in that they only mediate the infection of the human coronavirus 229E and the porcine corona virus TGEV, respectively (Delmas et aI., 1994; Kolb et aI., 1996) . In contrast, the feline APN protein is able to mediate infection of FIPV, TGEV, HCV 229E and CCV (Tresnan et aI., Coronaviruses and Arteriviruses, edited by Enjuanes et at. Plenum Press, New York, 1998 61 1996 . However, the feline coronavirus FIPV can only utilise fAPN as a receptor. By using chimeric molecules assembled from hAPN and pAPN the determinants which play an essential role in the infection of HCV 229E and TGEV have been identified (Delmas et a!., 1994; Kolb et a!., 1996) . The region encompassing pAPN amino acids 717-813 has been delimited as the protein segment which is critically involved in TGEV infection via APN (Delmas et a!., 1994) . In contrast, a region located in the amino-terminal part of hAPN (hAPN amino acids 260--353) has been defined as being essential for the infection of HCV 229E via hAPN (Kolb et a!., 1996) . Crandell feline kidney (CRFK) cells are susceptible to FIPV, TGEV and HCV 229E. We anticipated that infection of HCV 229E into these cells would be mediated by a feline homologue of hAPN. We have isolated a fAPN cDNA from CRFK cells and by using chimeric molecules assembled from human, porcine and feline APN we have delimited the fAPN amino acid regions, which are involved in the HCV 229E, TGEV and FIPV receptor function. Within these regions we have analysed the amino acid residues which play an essential role in mediating corona virus infections.
MATERIALS AND METHODS

Cells and Viruses
The HCV 229E isolate used in these studies was described previously. TGEV strain Purdue 46 was obtained from G. Herrler, University of Marburg, Germany. FIPV strain 79-1146 was obtained from R. de Groot, University of Utrecht, The Netherlands. CRFK cells (ECACC 86093002) and 293 HEK cells (ECACC 85120602) were cultivated according to standard techniques. Transfections were performed as described (Kolb et a!., 1996) .
Recombinant DNA
The construction of cDNA clones and chimeras used during these studies are described elsewhere (Delmas et a!., 1994; Kolb et a!., 1996; Kolb et aI., submitted; Hegyi et aI., in preparation) .
Protein Detection
Detection of de novo synthesised HCV 229E or TGEV antigens was performed by Western blotting (Kolb et ai., 1996) . Detection of de novo synthesised FIPV antigens was done by immune-precipitation of viral proteins from infected and metabolically labelled cells as described (Grosse and Siddell, 1994) . The enzymatic activity of APN proteins was analysed as described (Kolb et aI., 1996) .
RESULTS
A feline APN cDNA was isolated from CRFK cells by reverse transcription-PCR. The primers used for the amplification were derived from nucleotide sequences which are conserved between the known mammalian APN genes. Two PCR products encompassing the complete fAPN cDNA were cloned into an expression vector and transfected into 293 HEK cells. Cells transfected with the fAPN expression construct became susceptible to infection with FIPV, TGEV and HCV 229E (Table 1 ). In accordance with published data (Delmas et aI., 1993) , transfection ofpAPN or hAPN expression vectors failed to induce susceptibility to FIPV infection (Table 1 ). The sequence of the fAPN cDNA derived from CRFK cells is highly homologous to the fAPN cDNA recently isolated from Fcwf cells (Tresnan et aI., 1996) . However, the predicted CRFK fAPN protein differs from the Fcwf fAPN protein by 16 amino acids (Kolb et aI., submitted) . In order to define the determinants in the fAPN protein which mediate the infection of HCV 229E a chimeric protein was generated (AP34) which carries fAPN amino acids 135-297 incorporated into a pAPN backbone (Table I; Fig. I) . This chimera was able to act as a receptor for HCV 229E, indicating that the critical determinants required for the infection of HCV 229E via feline APN are present within fAPN amino acids 135-297 (Kolb et aI., submitted) . The sequences of human, feline and porcine APN were aligned by using the CLUSTAL method of the MegAlign program (DNA Star, Madison, WI, USA). This alignment reveals that the chimeras AP32, which carries hAPN amino acids 260-353 inserted into a pAPN backbone (Kolb et aI., 1996) , and AP34 overlap by as little as 39 amino acids (Fig. 1) . These 39 amino acids contain a sequence which is highly divergent between the 3 APN proteins (Fig. 1 ). Within this short sequence the hAPN and fAPN are more related to each other that to the pAPN protein. A number of site directed mutants was therefore generated to more closely characterise this amino acid segment. In one of these mutants the pAPN amino acids 283-290 (QSVNETAQ) were replaced by the hAPN amino acids 288-295 (DYVEKQAS) (mutant AP35, Table 2 ). This replacement of 6 amino acids of pAPN by the corresponding hAPN residues was sufficient to convert pAPN into a functional receptor for HCV 229E (Kolb et aI., submitted) . At the same time this mutant was still able to mediate the infection of TGEV, suggesting that the exchanged amino acid residues do not play an essential role for the TGEV-pAPN interaction ( Table 2) .
A. F. Kolb et aI. susceptibility to infection HCV229E TOEV + The hAPN amino acid segment 288-295 was analysed for features that are similar in the fAPN sequence and different in the pAPN sequence to establish a molecular basis for the ability of hAPN and fAPN to act as receptors for HeV 229E. A first obvious difference between the pAPN sequence on the one side and the hAPN and fAPN sequences on the other is the presence of aN-linked glycosylation signal in the pAPN protein (residues: 283-290 QSVNETAQ) which is absent from hAPN and fAPN. The glycosylation signal was removed by site directed mutagenesis (converting the pAPN amino acids 283-290 to Table 2 ), suggesting that the absence of the glycosylation signal within this protein domain is not sufficient to convert pAPN into a receptor for HCV 229E. The mutant AP36 was still able to act as a receptor for TGEV, again indicating that the mutated sequence does not play an essential role in the pAPN-TGEV interaction.
Another prominent property which distinguishes hAPN and fAPN from pAPN is the presence of a tyrosine residue (hAPN: Y-289; fAPN Y-287) and a positively charged residue (hAPN: K-292; fAPN: R-291) within the critical amino acid segment defined by mutant AP35 (Fig. I) . A computer prediction using the predict-protein program (Rost, 1996) also indicates that this amino acid segment is located within an alpha-helical domain of the APN protein. The tyrosine residue and the positively charged residue are predicted to lie on the same surface of the helix. These two residues may therefore playa critical role in the HCV 229E receptor function of hAPN and fAPN. Two further mutants were thus generated in which the pAPN sequence QSVNETAQ (residues 283-290) was converted to QYVNERAQ (mutant AP37) or QYVNKTAQ (mutant AP38). Both of these mutants, however, failed to convert pAPN into a receptor for HCV 229E (Table 2) . Again, both mutants could still act as receptors for TGEV ( Table 2) .
The amino acid residues which are critically involved in mediating the HCV 229E receptor function of both hAPN and fAPN are located within the amino-terminal part of the protein (Fig. I) . The mutant AP34, however, failed to mediate FIPV infection, suggesting that the determinants which are essential for the FlPV receptor function of fAPN are not present within this chimera (Kolb et aI., submitted) . The determinants mediating TGEV and CCV infection have been mapped to the carboxy-terminal part of porcine and canine APN, respectively (Delmas et aI., 1994; Benbacer et aI., 1997) . To investigate whether the determinants mediating the FlPV receptor function are also located within the C-terminal part of fAPN, we generated a chimera (AP33) in which fAPN amino acids 67~40 were integrated into a hAPN backbone (Table I, Fig. 2) . Transfection/infection experiments revealed that AP33 can mediate infection of FlPV and TGEV (Hegyi et aI., in prep.) . This indicates that a) the determinants which are essential for the fAPN-FIPV interaction are indeed located within the C-terminal segment of fAPN, b) TGEV and FlPV interact with similar determinants within their respective receptor proteins and c) as in hAPN and pAPN, HCV 229E and TGEV interact with different amino acid segments of the fAPN protein.
In order to define critical amino acid residues within the domain involved in TGEV, FIPV and CCV reception we aligned the amino acid sequences of APN proteins which have been analysed for their coronavirus receptor function (Fig. 2) . Chimeric proteins carrying fragments of the C-terminal part of porcine, canine, bovine and feline APN (encoding the amino acids indicated in Table 1 ) within an hAPN backbone can all act as functional receptors for TGEV (Delmas et aI., 1994; Benbacer et aI., 1997) . Only the corresponding hAPN sequence is unable to mediate the TGEV-receptor function, suggesting that residues critically involved in the TGEV-APN interaction are not present within the hAPN sequence. As few as 9 amino acids in the 717-813 (pAPN) region are specific for the human APN sequence (Fig. 2) .
By using site directed mutagenesis we converted two stretches of amino acids within the C-terminal part of the hAPN protein (alone and in combination) to the corresponding porcine sequence (Table 3) . None of the mutations, however, converted hAPN into a functional receptor for TGEV. The EEE->QDQ mutation in the mutant AP42 rather rendered the APN protein non-functional in that the expressed protein neither showed any HCV 229E receptor activity nor retained its aminopeptidase function (Table 3 ). The catalytic centre of the hAPN protein as well as the stretch of amino acids which plays an essential role in the Hev 229E receptor function of hAPN is distant to the site of the EEE->QDQ mutation in the primary structure. This result may thus suggest that the determinants identified as being essential for the HeV 229E-and TGEV-receptor function of human, porcine and feline APN are not independent protein domains. Most of the sequenced mammalian APN proteins carry the EEE sequence at the position corresponding to pAPN amino acids 806-808, whereas the QDQ sequence is unique to the porcine APN protein (Table 3) . As the introduction of the QDQ sequence into hAPN destroys the HeV 229E receptor function and the enzymatic activity, a second site in the pAPN protein must have a compensatory effect to ensure the proper biological function of pAPN. 
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DISCUSSION
We have identified, by using chimeric APN proteins and site directed mutagenesis, a short amino acid segment in the hAPN protein which is critically involved in mediating the HCV 229E receptor function (Kolb et aI., submitted) . Additionally, we have demonstrated that the determinants in the fAPN protein which mediate reception of HCV 229E and TGEV are located in similar parts of the protein as the corresponding determinants in hAPN and pAPN (Kolb et aI., 1996; Delmas et aI., 1994) . The utilisation of different determinants of the receptor protein may also reflect the serological and genetical differences between HCV 229E and the other group I coronaviruses like TGEV, FIPV and CCV (Siddell, 1995) . In the absence of an APN crystal structure, however, it is difficult to predict whether these determinants are really independent protein domains or rather assemble into a single epitope which mediates coronavirus infections.
